Spectroscopic behavior of bufotenine and bufotenine N-oxide: Solvent and pH effects and interaction with biomembrane models.
Gustavo Almeida E Silva, Vinícius Galvão Wakui, Lucília Kato, Cássia A Marquezin
Biochimica et Biophysica Acta (BBA) - Biomembranes April 1, 2024 DOI: 10.1016/j.bbamem.2024.184304 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Bufotenine and bufotenine N-oxide in various media and biomembrane models |
| Keywords | Bufotenine Liposome Micelle Uv/visible spectroscopy Biochemistry Spectroscopy uv-vis spectroscopy Absorption spectroscopy Fluorescence fluorometry Fluorescence spectroscopy Membrane biophys |
| Citations | 2 |
| Key findings | Bufotenine and bufotenine N-oxide interact with micelles and liposomes without changing lipid bilayer fluidity, and their fluorescence spectra vary with pH and solvent. |
Abstract
Bufotenine is a fluorescent analog of Dimethyltryptamine (DMT) that has been widely studied due to its psychedelic properties and biological activity. However, little is known about its spectroscopic properties in different media. Thus, we present in this work, for the first time, the spectroscopic behavior of bufotenine and bufotenine N-oxide by means of their fluorescence properties. Both molecules exhibit changes in optical absorption and emission spectra with variations in pH of the medium and in different solvents. Assays in the presence of biomembranes models, like micelles and liposomes, were also performed. In surfactants titration experiments, the spectral shift observed in fluorescence shows the interaction of both molecules with pre-micellar structures and with micelles. Steady state anisotropy measurements show that both bufotenine and bufotenine N-oxide, in the studied concentration range, interact with liposomes without causing changes in the fluidity of the lipid bilayer. These results can be useful in studies that aim at searching for new compounds, inspired by bufotenine and bufotenine N-oxide, with relevant pharmacological activities and also in studies that use these molecules as markers of psychiatric disorders.
Citations in the library
Cites 16
- Psilocybin – Summary of knowledge and new perspectives European Neuropsychopharmacology December 17, 2013
- Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT) ACS Chemical Neuroscience July 23, 2018
- 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines. ACS Chemical Neuroscience February 1, 2023
- Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine. Journal of Psychoactive Drugs 2001
- Bufotenine: toward an understanding of possible psychoactive mechanisms. Journal of Psychoactive Drugs 2000
and 11 more in the library